Climb Bio, Inc. (CLYM)
10.36
-0.51
(-4.69%)
USD |
NASDAQ |
Nov 13, 16:00
10.36
0.00 (0.00%)
After-Hours: 19:59
Climb Bio Shareholders Equity (Quarterly) : 228.05M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 228.05M |
| June 30, 2026 | 239.55M |
| March 31, 2026 | 148.08M |
| December 31, 2025 | 160.48M |
| September 30, 2025 | 177.00M |
| June 30, 2025 | 185.76M |
| March 31, 2025 | 193.38M |
| December 31, 2024 | 211.88M |
| September 30, 2024 | 218.78M |
| June 30, 2024 | 222.28M |
| March 31, 2024 | 106.38M |
| December 31, 2023 | 107.60M |
| Date | Value |
|---|---|
| September 30, 2023 | 109.74M |
| June 30, 2023 | 112.50M |
| March 31, 2023 | 116.86M |
| December 31, 2022 | 128.72M |
| September 30, 2022 | 134.36M |
| June 30, 2022 | 142.24M |
| March 31, 2022 | 155.14M |
| December 31, 2021 | 167.20M |
| September 30, 2021 | 176.66M |
| June 30, 2021 | 101.91M |
| March 31, 2021 | 49.62M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 416.53M |
| Cullinan Therapeutics, Inc. | 281.28M |
| Q32 Bio, Inc. | 287.67M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 236.56M |
| Total Liabilities (Quarterly) | 8.511M |
| Debt to Equity Ratio | 0.0047 |
| Current Ratio | 26.58 |
| Net Debt Paydown Yield | -0.01% |